FDA-Inspected Site

Huvepharma, Inc.

12 FDA inspections are on record for Huvepharma, Inc. in Saint Louis, United States.

483· Form 483 issued

Saint Louis, United States · Last updated July 10, 2026

Overview

  • 12 FDA inspections are on record.
  • 10 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-01-17.

At a glance

Inspections

12

Form 483s

10

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
13 Jan 2025 – 17 Jan 2025Human Drugs483On file
23 Jan 2023 – 30 Jan 2023Animal Drugs & Feeds483On file
3 Aug 2021 – 10 Aug 2021Animal Drugs & Feeds483View 483 →
14 May 2018 – 22 May 2018Animal Drugs & Feeds483View 483 →
6 Oct 2016 – 26 Oct 2016Animal Drugs & Feeds483On file
17 Aug 2015 – 1 Sep 2015Animal Drugs & Feeds483On file
3 Jun 2014 – 2 Jul 2014Animal Drugs & Feeds483View 483 →
14 Feb 2013 – 28 Feb 2013Animal Drugs & FeedsWLView 483 →
16 Jun 2011Not recorded483View 483 →
10 Sep 2009Not recorded483On file
1 May 2008Not recordedClean
18 Aug 2004Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

10 Aug 2021
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Carl A Huffman, Torrey M Ward

10 Aug 2021
21 CFR 211.125(a)

Strict control not exercised over labeling issued

Cited by Carl A Huffman, Torrey M Ward

10 Aug 2021
21 CFR 211.194(a)(2)

Suitability of testing methods verified

Cited by Carl A Huffman, Torrey M Ward

22 May 2018
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Kellia N Hicks

22 May 2018
21 CFR 211.68(b)

Computer control of master formula records

Cited by Kellia N Hicks

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.125(a)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.25(a)Cited across public-safe Form 483 observations2x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.142Cited across public-safe Form 483 observations1x
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(7)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.67(c)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x
21 CFR 211.80(b)Cited across public-safe Form 483 observations1x
21 CFR 226.110Cited across public-safe Form 483 observations1x
21 CFR 226.115Cited across public-safe Form 483 observations1x
21 CFR 226.20(b)Cited across public-safe Form 483 observations1x
21 CFR 226.40(b)Cited across public-safe Form 483 observations1x
21 CFR 226.40(d)Cited across public-safe Form 483 observations1x
21 CFR 226.40(e)Cited across public-safe Form 483 observations1x
21 CFR 226.58(b)Cited across public-safe Form 483 observations1x
21 CFR 226.58(d)Cited across public-safe Form 483 observations1x
21 CFR 226.80(b)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Huvepharma, Inc.'s 10 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat